SCHEMBL3064482

SCHEMBL3064482

Cc1nn(C)c(=O)c(-c2nc(-c3ccc(Cl)cc3)sc2C)c1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APEX1 P27695 1/20 0.43
RAB9A P51151 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
KDM4E B2RXH2 3/20 0.42
NPC1 O15118 2/20 0.42
POLB P06746 2/20 0.42
ALDH1A1 P00352 3/20 0.42
KMT2A Q03164 3/20 0.42
MAPT P10636 3/20 0.42
MEN1 O00255 2/20 0.42
PDE7A Q13946 2/20 0.40
PDE4D Q08499 1/20 0.40
CASP3 P42574 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
GAA P10253 1/20 0.39
LMNA P02545 2/20 0.39
S1PR2 O95136 1/20 0.39
TDP2 O95551 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14064295 0.81 APEX1 (0.46) APEX1RAB9ASMN1; SMN2KDM4ENPC1
SCHEMBL14064271 0.74 HRH3 (0.44) APEX1RAB9ASMN1; SMN2KDM4ENPC1
SCHEMBL3789703 0.71 MAPK8 (0.38) RAB9ASMN1; SMN2NPC1ALDH1A1KMT2A
SCHEMBL14064298 0.71 APEX1 (0.40) APEX1RAB9ASMN1; SMN2KDM4ENPC1
SCHEMBL25245797 0.70 SMN1; SMN2 (0.57) APEX1SMN1; SMN2ALDH1A1KMT2AMAPT
SCHEMBL470078 0.70 NPC1 (0.36) RAB9ASMN1; SMN2KDM4ENPC1POLB
SCHEMBL14064297 0.70 MAPT (0.39) APEX1RAB9ASMN1; SMN2KDM4ENPC1
SCHEMBL513374 0.70 NPC1 (0.39) RAB9AKDM4ENPC1POLBALDH1A1
SCHEMBL30254871 0.69 MIF (0.38) PDE7APDE4DPDE5APDE1APDE1B
SCHEMBL919364 0.68 MAPT (0.38) RAB9ASMN1; SMN2NPC1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2225211-B1 HERBICIDAL PYRIDAZINONE DERIVATIVES DU PONT (US) 2013-10-02 EP disclosed
US-20100267561-A1 HERBICIDAL PYRIDAZINONE DERIVATIVES E. I. DU PONT DE NEMOURS AND COMPANY 2010-10-21 US disclosed
EP-2225211-A1 HERBICIDAL PYRIDAZINONE DERIVATIVES E. I. du Pont de Nemours and Company (US) 2010-09-08 EP disclosed
WO-2009086041-A1 HERBICIDAL PYRIDAZINONE DERIVATIVES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2009-07-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267561-A1 HERBICIDAL PYRIDAZINONE DERIVATIVES CYP1A1, CYP1B1, CBR3 APEX1 992/4885RAB9A 3035/4885SMN1; SMN2 4277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.